Daily as of 3 Nov 16:00 ET
- Price
- between the two $26.33 vs 50 $25.81 / 200 $28.08
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 💀Death cross 14 Sep 2026 · projected 13 bars out
BEAM | Beam TherapeuticsNASDAQHealthcareCommon stock golden cross and death cross projections, cross tests and history
$26.33
+$0.46 (+1.78%)
Beam Therapeutics (BEAM) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2021.
The 50 SMA has sat below the 200 on the daily since Sep 2026, with no cross projected inside the 30 bars Cruxta tracks. Price sits between the 50 and the 200 on the daily, the weekly and the 4-hour.
Timeframe summary
Weekly as of 30 Oct 16:00 ET
- Price
- between the two $27.23 vs 50 $27.76 / 200 $26.86
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 🟨Golden cross week of 31 Aug 2026 · projected 9 bars out · tested 5 bars
4-hour as of 3 Nov 13:30 ET
- Price
- between the two $26.86 vs 50 $25.07 / 200 $27.86
- Projection
- 🟨Golden cross estimated in 20 to 29 bars
- Test
- No active test
- Last cross
- 💀Death cross 6 Aug 2026 · projected 29 bars out
Cross history
| Crossed | Direction | Timeframe | Projected | Cross test |
|---|---|---|---|---|
| 14 Sep 2026 | 💀Death moderate | daily | 13 bars out | Not tested |
| week of 31 Aug 2026 | 🟨Golden moderate | weekly | 9 bars out | 5 bar cross test |
| 6 Aug 2026 | 💀Death | 4-hour | 29 bars out | Not tested |
| 1 May 2026 | 🟨Golden | 4-hour | 29 bars out | 2 bar cross test |
| 25 Mar 2026 | 💀Death | 4-hour | 25 bars out | Not tested |
About BEAM
ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$40.5M
4-hour coverageYes, since Oct 2025
History on recordSince 2021
SectorHealthcare
Cap bandmid